Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
2196.HK Stock Price Chart
Explore Shanghai Fosun Pharmaceutical (Group) Co., Ltd. interactive price chart. Choose custom timeframes to analyze 2196.HK price movements and trends.
2196.HK Company Profile
Discover essential business fundamentals and corporate details for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
30 Oct 2012
Employees
40.56K
Website
https://www.fosunpharma.comCEO
Deyong Wen
Description
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
2196.HK Financial Timeline
Browse a chronological timeline of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 25 Mar 2026
Upcoming earnings on 29 Oct 2025
Earnings released on 26 Aug 2025
EPS came in at $0.70 , while revenue for the quarter reached $21.29B , beating expectations by +109.43%.
Dividend declared on 24 Jul 2025
A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 22 Aug 2025.
Earnings released on 29 Apr 2025
EPS came in at $0.29 falling short of the estimated $0.30 by -3.33%, while revenue for the quarter reached $10.05B , beating expectations by +2.41%.
Earnings released on 24 Mar 2025
EPS came in at $0.29 falling short of the estimated $0.30 by -3.33%, while revenue for the quarter reached $10.80B , beating expectations by +5.03%.
Earnings released on 29 Oct 2024
EPS came in at $0.29 falling short of the estimated $0.30 by -3.33%, while revenue for the quarter reached $11.56B , beating expectations by +6.67%.
Earnings released on 28 Aug 2024
EPS came in at $0.23 falling short of the estimated $0.28 by -17.86%, while revenue for the quarter reached $11.07B , missing expectations by -2.34%.
Dividend declared on 26 Jul 2024
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 23 Aug 2024.
Earnings released on 29 Apr 2024
EPS came in at $0.23 falling short of the estimated $0.35 by -34.29%, while revenue for the quarter reached $10.99B , missing expectations by -8.34%.
Earnings released on 26 Mar 2024
EPS came in at $0.05 falling short of the estimated $0.41 by -87.80%, while revenue for the quarter reached $9.98B .
Earnings released on 31 Dec 2023
EPS came in at $0.04 , while revenue for the quarter reached $11.84B .
Dividend declared on 31 Jul 2023
A dividend of $0.46 per share was announced, adjusted to $0.46. The dividend was paid on 24 Aug 2023.
Earnings released on 30 Jun 2023
EPS came in at $0.32 , while revenue for the quarter reached $11.38B .
Earnings released on 31 Mar 2023
EPS came in at $0.42 , while revenue for the quarter reached $12.41B .
Earnings released on 29 Mar 2023
EPS came in at $0.48 surpassing the estimated $0.38 by +26.32%, while revenue for the quarter reached $14.06B .
Earnings released on 30 Sept 2022
EPS came in at $0.39 , while revenue for the quarter reached $11.28B .
Earnings released on 2 Sept 2022
EPS came in at $0.42 falling short of the estimated $0.69 by -39.13%, while revenue for the quarter reached $12.83B .
Dividend declared on 8 Jun 2022
A dividend of $0.66 per share was announced, adjusted to $0.66. The dividend was paid on 4 Jul 2022.
Earnings released on 27 Apr 2022
EPS came in at $0.18 falling short of the estimated $0.37 by -51.35%, while revenue for the quarter reached $12.79B .
Earnings released on 23 Mar 2022
EPS came in at $0.46 surpassing the estimated $0.34 by +35.29%, while revenue for the quarter reached $14.64B .
Earnings released on 27 Oct 2021
EPS came in at $0.42 falling short of the estimated $0.47 by -10.64%, while revenue for the quarter reached $12.18B .
Earnings released on 24 Aug 2021
EPS came in at $0.64 falling short of the estimated $0.95 by -32.63%, while revenue for the quarter reached $10.68B .
Dividend declared on 7 Jul 2021
A dividend of $0.52 per share was announced, adjusted to $0.52. The dividend was paid on 3 Aug 2021.
Earnings released on 24 Apr 2021
EPS came in at $0.33 falling short of the estimated $0.55 by -40.00%, while revenue for the quarter reached $9.54B .
Earnings released on 30 Mar 2021
EPS came in at $0.46 surpassing the estimated $0.44 by +4.55%, while revenue for the quarter reached $9.74B .
Earnings released on 29 Oct 2020
EPS came in at $0.30 falling short of the estimated $0.31 by -3.23%, while revenue for the quarter reached $9.21B .
2196.HK Stock Performance
Access detailed 2196.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.